Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Current Opinion in Obstetrics & Gynecology|December 14, 2019
Latest clinical evidence of maintenance therapy in ovarian cancerChristine S WalshGynecologic Oncology|March 1, 2015
Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapyChristine S WalshCurrent Opinion in Obstetrics & Gynecology|December 24, 2015
Leveraging DNA repair deficiency in gynecologic oncologyChristine S Walsh, Melissa HodeibCurrent Oncology Reports|November 10, 2007
Contemporary progress in ovarian cancer screeningChristine S Walsh, B Y KarlanMolecular Diagnosis & Therapy|February 4, 2010
Molecular signatures of ovarian cancer: from detection to prognosisChristine S Walsh, Beth Y KarlanJAMA Network Open|December 9, 2020
Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United StatesCourtney A Penn, Melissa S Wong, Christine S WalshScientific Reports|October 7, 2025
Immunocompetent C57BL/6 syngeneic mouse ovarian cancer models with defined genetic alterationsHasmik Agadjanian, Beth Y Karlan, Christine S Walsh, et al.Gynecologic Oncology|November 25, 2006
Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer riskChristine S Walsh, Carl W Miller, Beth Y Karlan, et al.Gynecologic Oncology|September 18, 2013
Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survivalElena S Diaz, Ann E Walts, Beth Y Karlan, et al.Leukemia Research|May 20, 2008
FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemiasJee Hoon Song, Nikolai Schnittke, April Zaat, et al.Pageof 6